CVE-2026-93886

CVE-2026-93886 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 8.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

IBM i 7.3, 7.4, 7.5, and 7.6 could allow a remote authenticated attacker to execute arbitrary script code due to improper validation of user-supplied input.

Frequently asked questions

What is CVE-2026-93886?
IBM i 7.3, 7.4, 7.5, and 7.6 could allow a remote authenticated attacker to execute arbitrary script code due to improper validation of user-supplied input.
How severe is CVE-2026-93886?
CVE-2026-93886 has a CVSS 3.x base score of 8.3, rated high severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is high, integrity high, and availability low.
Is CVE-2026-93886 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (9th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-93886?
CVE-2026-93886 affects Ibm I. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-93886?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-93886 published?
CVE-2026-93886 was published on 2026-10-13 and last updated on 2026-10-14.

References

Affected products (1)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →